Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Michele Fox

Concepts (269)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cells
9
2025
189
1.550
 Why?
Hematopoietic Stem Cell Transplantation
14
2025
610
1.490
 Why?
Hematopoietic Stem Cell Mobilization
11
2018
63
1.370
 Why?
Multiple Myeloma
27
2025
3082
1.350
 Why?
Blood Component Removal
5
2025
17
0.950
 Why?
Fetal Blood
4
2026
79
0.870
 Why?
Antigens, CD34
10
2025
76
0.800
 Why?
Blood Platelets
5
2017
247
0.760
 Why?
Leukapheresis
4
2025
19
0.630
 Why?
Blood Banks
2
2026
22
0.580
 Why?
Melphalan
4
2016
180
0.530
 Why?
Bone Marrow Transplantation
4
2016
110
0.510
 Why?
Purpura, Thrombotic Thrombocytopenic
2
2018
16
0.490
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1043
0.490
 Why?
Plasma Exchange
3
2015
25
0.460
 Why?
Transplantation, Autologous
9
2025
488
0.420
 Why?
Cell Separation
2
2013
76
0.380
 Why?
Pregnant Women
1
2023
71
0.370
 Why?
Health Knowledge, Attitudes, Practice
1
2026
523
0.360
 Why?
Humans
45
2026
53230
0.350
 Why?
Killer Cells, Natural
2
2015
113
0.350
 Why?
Cell Proliferation
5
2018
1031
0.330
 Why?
Immunotherapy, Adoptive
2
2015
163
0.320
 Why?
Myelodysplastic Syndromes
2
2013
87
0.320
 Why?
Adult
23
2026
14534
0.320
 Why?
Granulocyte Colony-Stimulating Factor
4
2012
64
0.320
 Why?
Thalidomide
4
2016
378
0.300
 Why?
Blood Transfusion
2
2017
127
0.300
 Why?
Blood Specimen Collection
1
2019
34
0.290
 Why?
Blood Volume
1
2019
62
0.290
 Why?
Education, Distance
1
2019
43
0.280
 Why?
Aged
21
2017
10429
0.280
 Why?
Clinical Laboratory Techniques
1
2018
28
0.280
 Why?
Cryopreservation
2
2025
41
0.270
 Why?
Obstetrics
1
2019
87
0.270
 Why?
Leukocytes, Mononuclear
1
2018
122
0.270
 Why?
Cyclooxygenase Inhibitors
1
2017
40
0.270
 Why?
Flow Cytometry
2
2016
400
0.260
 Why?
Blood Grouping and Crossmatching
1
2017
5
0.260
 Why?
Chromosome Aberrations
3
2016
297
0.260
 Why?
Blood Coagulation
1
2017
65
0.260
 Why?
Middle Aged
21
2018
13419
0.250
 Why?
Female
23
2026
28782
0.250
 Why?
Aspirin
1
2017
123
0.240
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
124
0.240
 Why?
Antibodies
1
2016
147
0.240
 Why?
Erythrocyte Transfusion
2
2015
53
0.240
 Why?
Platelet Aggregation Inhibitors
1
2017
213
0.230
 Why?
Hemoglobins, Abnormal
1
2015
4
0.220
 Why?
Heparin
1
2015
86
0.220
 Why?
Thrombocytopenia
1
2015
89
0.220
 Why?
Stem Cell Transplantation
2
2013
191
0.220
 Why?
Factor VIII
1
2014
24
0.220
 Why?
ADAM Proteins
1
2014
21
0.210
 Why?
Leukocytes
2
2011
58
0.210
 Why?
Retrospective Studies
9
2025
6819
0.210
 Why?
Internship and Residency
1
2019
439
0.210
 Why?
Anemia, Sickle Cell
1
2015
105
0.200
 Why?
Follow-Up Studies
8
2024
2318
0.200
 Why?
Male
21
2019
27435
0.200
 Why?
Antiretroviral Therapy, Highly Active
1
2013
32
0.190
 Why?
Leukemia
1
2013
67
0.190
 Why?
Afibrinogenemia
1
2012
5
0.190
 Why?
Neoplasm Recurrence, Local
2
2015
647
0.190
 Why?
Graft Survival
4
2011
157
0.190
 Why?
Prognosis
6
2018
2118
0.180
 Why?
Aldehyde Dehydrogenase
1
2011
24
0.180
 Why?
Transplantation Conditioning
3
2003
96
0.180
 Why?
Young Adult
5
2026
4511
0.170
 Why?
Pregnancy
3
2026
2608
0.170
 Why?
Boronic Acids
2
2013
180
0.170
 Why?
Pyrazines
2
2013
188
0.170
 Why?
Plateletpheresis
1
2010
7
0.170
 Why?
Blood Preservation
1
2010
27
0.170
 Why?
Transplantation, Homologous
5
2016
154
0.160
 Why?
Blood Proteins
1
2010
84
0.160
 Why?
Anaphylaxis
1
2010
69
0.160
 Why?
Chromosomes, Human, Pair 1
2
2007
95
0.150
 Why?
Cell Survival
5
2011
600
0.150
 Why?
Graft vs Host Disease
5
2003
93
0.150
 Why?
Receptors, KIR
1
2008
11
0.150
 Why?
HIV Infections
1
2013
402
0.140
 Why?
Gene Expression Regulation, Neoplastic
2
2016
868
0.140
 Why?
Myeloablative Agonists
1
2007
32
0.130
 Why?
Cell Movement
2
2006
279
0.130
 Why?
Immunosuppressive Agents
2
2014
253
0.130
 Why?
Treatment Outcome
11
2013
5595
0.130
 Why?
Dexamethasone
3
2024
429
0.130
 Why?
Models, Genetic
1
2006
169
0.120
 Why?
Risk Factors
7
2015
4017
0.120
 Why?
Osteogenesis
2
2006
374
0.120
 Why?
Models, Statistical
1
2007
229
0.120
 Why?
Combined Modality Therapy
4
2014
640
0.120
 Why?
Cytokines
2
2006
627
0.110
 Why?
Platelet Count
3
2017
68
0.110
 Why?
Macrophages
1
2018
380
0.110
 Why?
Gene Expression Profiling
2
2007
1112
0.110
 Why?
Enzyme-Linked Immunosorbent Assay
2
2015
233
0.110
 Why?
Incidence
3
2017
1085
0.110
 Why?
Time Factors
1
2010
2991
0.110
 Why?
Antineoplastic Agents
3
2012
1232
0.100
 Why?
Cytotoxicity Tests, Immunologic
2
2016
26
0.100
 Why?
Disease-Free Survival
3
2016
466
0.100
 Why?
Bone Marrow Cells
1
2004
188
0.100
 Why?
Bone Diseases
1
2004
94
0.100
 Why?
Metaphase
2
2016
47
0.100
 Why?
Cell Count
3
2011
141
0.100
 Why?
Osteoblasts
1
2006
480
0.100
 Why?
Cyclosporine
1
2003
64
0.090
 Why?
Blood Group Incompatibility
1
2002
4
0.090
 Why?
Tacrolimus
1
2003
61
0.090
 Why?
ABO Blood-Group System
1
2002
16
0.090
 Why?
Universities
1
2023
186
0.090
 Why?
Kaplan-Meier Estimate
3
2007
487
0.090
 Why?
Coculture Techniques
3
2018
146
0.090
 Why?
Osteoclasts
1
2004
428
0.080
 Why?
Models, Biological
1
2004
737
0.080
 Why?
T-Lymphocyte Subsets
1
2001
39
0.080
 Why?
T-Lymphocytes, Cytotoxic
1
2010
67
0.080
 Why?
Lung Diseases
1
2001
84
0.080
 Why?
Prospective Studies
4
2016
2411
0.080
 Why?
Thrombosis
1
2003
250
0.080
 Why?
Heart Failure
1
2006
531
0.080
 Why?
Cancer Vaccines
1
2010
79
0.080
 Why?
Dendritic Cells
1
2010
133
0.080
 Why?
Erythroid Precursor Cells
1
2019
15
0.070
 Why?
Birth Weight
1
2019
119
0.070
 Why?
Hematocrit
1
2018
40
0.070
 Why?
Medical Waste
1
2017
2
0.070
 Why?
Cell Aggregation
1
2017
5
0.070
 Why?
Antineoplastic Agents, Alkylating
2
2008
78
0.070
 Why?
Lymphoma
1
2018
71
0.070
 Why?
Program Evaluation
1
2019
359
0.070
 Why?
Arkansas
2
2017
2068
0.070
 Why?
Lymphoma, Follicular
1
2017
27
0.060
 Why?
Lung
1
2001
481
0.060
 Why?
Histocompatibility Antigens Class I
1
2017
47
0.060
 Why?
Logistic Models
2
2017
947
0.060
 Why?
Adolescent
3
2015
6907
0.060
 Why?
Neoplasms
1
2007
1334
0.060
 Why?
Risk
1
2017
306
0.060
 Why?
Fibrosis
1
2017
198
0.060
 Why?
Dose-Response Relationship, Drug
3
2008
1367
0.060
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2017
110
0.060
 Why?
Curriculum
1
2019
409
0.060
 Why?
Recurrence
2
2008
694
0.060
 Why?
Hemorrhage
1
2017
226
0.060
 Why?
Hemoglobin J
1
2015
3
0.060
 Why?
Hemoglobin, Sickle
1
2015
5
0.060
 Why?
Hemoglobin C
1
2015
6
0.060
 Why?
Blood Donors
1
2015
21
0.060
 Why?
Diagnosis, Differential
1
2018
1038
0.050
 Why?
Neoplasm Proteins
1
2016
330
0.050
 Why?
Reproducibility of Results
1
2017
1219
0.050
 Why?
Age Factors
3
2005
1136
0.050
 Why?
Autoantibodies
1
2014
120
0.050
 Why?
Blotting, Western
1
2015
587
0.050
 Why?
CD4 Lymphocyte Count
1
2013
33
0.050
 Why?
Viral Load
1
2013
83
0.050
 Why?
Transplantation Chimera
3
2003
16
0.050
 Why?
Immunohistochemistry
1
2015
975
0.050
 Why?
Acute Disease
1
2013
393
0.050
 Why?
Benzylamines
1
2012
14
0.050
 Why?
Receptors, CXCR4
1
2012
30
0.050
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
51
0.040
 Why?
Heterocyclic Compounds
1
2012
30
0.040
 Why?
Infant, Newborn
1
2019
2913
0.040
 Why?
Clinical Protocols
1
2012
109
0.040
 Why?
Immune Tolerance
1
2011
91
0.040
 Why?
Dimethyl Sulfoxide
1
2010
12
0.040
 Why?
Isotonic Solutions
1
2010
19
0.040
 Why?
Platelet Transfusion
1
2010
33
0.040
 Why?
P-Selectin
1
2010
27
0.040
 Why?
Sodium Chloride
1
2010
53
0.040
 Why?
Algorithms
2
2005
667
0.040
 Why?
Platelet Aggregation
1
2010
77
0.040
 Why?
Platelet Activation
1
2010
48
0.040
 Why?
Multivariate Analysis
2
2007
598
0.040
 Why?
Feasibility Studies
1
2011
411
0.040
 Why?
Hypersensitivity
1
2010
83
0.040
 Why?
Haplotypes
1
2008
96
0.040
 Why?
Ligands
1
2008
203
0.030
 Why?
Nitric Oxide Synthase Type II
1
2018
64
0.030
 Why?
Polyethylene Glycols
1
2008
95
0.030
 Why?
Arginase
1
2018
40
0.030
 Why?
Hemoglobins
1
2008
114
0.030
 Why?
Age Distribution
1
2007
175
0.030
 Why?
Cytogenetic Analysis
1
2007
79
0.030
 Why?
Recombinant Proteins
1
2008
489
0.030
 Why?
Antineoplastic Agents, Hormonal
1
2007
56
0.030
 Why?
Tissue Donors
2
2003
130
0.030
 Why?
Multigene Family
1
2006
50
0.030
 Why?
Mice
2
2018
5982
0.030
 Why?
Chromosome Deletion
1
2007
138
0.030
 Why?
Chromosome Mapping
1
2006
145
0.030
 Why?
In Situ Hybridization, Fluorescence
1
2007
266
0.030
 Why?
Angiogenesis Inhibitors
1
2007
186
0.030
 Why?
Cell Line
1
2008
1016
0.030
 Why?
Interleukin-10
1
2006
81
0.030
 Why?
Cell Communication
1
2006
73
0.030
 Why?
Leukemia, Myeloid, Acute
1
2007
208
0.030
 Why?
Neoplasms, Experimental
1
2006
112
0.030
 Why?
Predictive Value of Tests
1
2007
934
0.030
 Why?
Stroke Volume
1
2006
150
0.030
 Why?
Ventricular Dysfunction, Left
1
2006
107
0.030
 Why?
Myocardial Ischemia
1
2006
129
0.030
 Why?
Mice, Transgenic
1
2006
561
0.030
 Why?
Bromodeoxyuridine
1
2004
17
0.030
 Why?
Receptor Activator of Nuclear Factor-kappa B
1
2004
33
0.030
 Why?
Annexin A5
1
2004
14
0.030
 Why?
Culture Media, Conditioned
1
2004
49
0.030
 Why?
Databases, Factual
1
2007
742
0.030
 Why?
Survival Rate
1
2006
949
0.030
 Why?
Tumor Necrosis Factor-alpha
1
2006
392
0.030
 Why?
Phagocytosis
1
2004
59
0.030
 Why?
Chronic Disease
1
2006
580
0.020
 Why?
Cell Division
1
2004
289
0.020
 Why?
Aged, 80 and over
2
2006
3494
0.020
 Why?
Plasmapheresis
1
2003
12
0.020
 Why?
RANK Ligand
1
2004
188
0.020
 Why?
Membrane Glycoproteins
1
2004
238
0.020
 Why?
Interleukin-6
1
2004
272
0.020
 Why?
Salvage Therapy
2
2003
138
0.020
 Why?
NF-kappa B
1
2004
327
0.020
 Why?
Cohort Studies
1
2006
1557
0.020
 Why?
Severity of Illness Index
1
2006
1049
0.020
 Why?
Red-Cell Aplasia, Pure
1
2002
7
0.020
 Why?
Child
1
2015
7379
0.020
 Why?
Carrier Proteins
1
2004
315
0.020
 Why?
Animals
2
2018
13526
0.020
 Why?
Antigens, CD
1
2003
217
0.020
 Why?
Survival Analysis
2
2003
659
0.020
 Why?
Gene Rearrangement, T-Lymphocyte
1
2001
2
0.020
 Why?
Lymphocyte Count
1
2001
20
0.020
 Why?
Cell Differentiation
1
2004
681
0.020
 Why?
Bronchoalveolar Lavage Fluid
1
2001
39
0.020
 Why?
Clone Cells
1
2001
76
0.020
 Why?
Graft Rejection
1
2002
166
0.020
 Why?
Disease Models, Animal
1
2006
1517
0.020
 Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
 Why?
CD40 Ligand
1
2010
14
0.020
 Why?
Hypersensitivity, Delayed
1
2010
18
0.020
 Why?
Interleukin-4
1
2010
40
0.020
 Why?
Immunity, Cellular
1
2010
64
0.020
 Why?
Adjuvants, Immunologic
1
2010
52
0.020
 Why?
Magnetic Resonance Imaging
1
2007
1583
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2001
145
0.020
 Why?
Interferon-gamma
1
2010
174
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
579
0.020
 Why?
CD4-Positive T-Lymphocytes
1
2001
166
0.020
 Why?
Transcription, Genetic
1
2001
374
0.020
 Why?
B-Lymphocytes
1
2010
178
0.020
 Why?
Vaccination
1
2010
310
0.020
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Confidence Intervals
1
2003
158
0.010
 Why?
Probability
1
2003
171
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Leukocyte Count
1
2003
71
0.010
 Why?
Infusions, Intravenous
1
2003
211
0.010
 Why?
Cyclophosphamide
1
2003
178
0.010
 Why?
Drug Administration Schedule
1
2003
370
0.010
 Why?
Remission Induction
1
2003
221
0.010
 Why?
Administration, Oral
1
2003
456
0.010
 Why?
Neutrophils
1
2003
153
0.010
 Why?
Doxorubicin
1
2003
247
0.010
 Why?
Cisplatin
1
2003
282
0.010
 Why?
Neoplasm Staging
1
2003
774
0.010
 Why?
Drug Resistance, Neoplasm
1
2003
350
0.010
 Why?
Disease Progression
1
2003
880
0.010
 Why?
Fox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (269) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department